Kurome Therapeutics
PrivateLast Round
Series A
Jun 10, 2021
Total Funding Raised
$19M
Company Overview
Kurome Therapeutics is a biotechnology company that develops small-molecule therapies targeting dysregulated immune signaling pathways in hematological cancers such as acute myeloid leukemia and myelodysplastic syndromes.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kurome Therapeutics Comparables
Compare Kurome Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eilean Therapeutics | 93% | |
| Arog Pharmaceuticals | 86% | |
| Hangzhou Polymed Biopharmaceuticals | 83% |
Kurome Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jun 10, 2021 | ||||
| Seed | Apr 29, 2020 |
Key People
Founding team and executive leadership
Kurome Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| QCA Ventures | Seed, Series A |
| CincyTech | Series A, Seed |
| Angel Physicians Fund | Seed |
| Medicxi | Series A |
| Affinity Asset Advisors | Series A |
Kurome Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Kurome Therapeutics's valuation, stock price, and market status.
Is Kurome Therapeutics a public or private company?
Kurome Therapeutics is a private company.
What is the current stock price of Kurome Therapeutics?
Kurome Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Kurome Therapeutics worth (valuation)?
Valuation information for Kurome Therapeutics is not publicly available.
Can I buy Kurome Therapeutics stock?
Kurome Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Kurome Therapeutics's last funding round?
Kurome Therapeutics's most recent funding round was Series A on June 10, 2021.
Who are the main investors in Kurome Therapeutics?
Key investors in Kurome Therapeutics include CincyTech, Medicxi, Affinity Asset Advisors.
Will Kurome Therapeutics IPO soon?
No public IPO plans have been announced for Kurome Therapeutics.
How can I track Kurome Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kurome Therapeutics's secondary market activity and sign up for updates.